
    
      Patients will be progressively enrolled in the study and undergo a screening visit to test
      for inclusion/exclusion criteria. Patients will then be randomized to receive either Lithium
      carbonate or placebo. Patients will visit study center at 2, 4, 8, 12, 24, 36 and 48 weeks,
      for endpoint and laboratory assessments.
    
  